These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6224681)

  • 1. Criteria for interpretation of agar diffusion susceptibility tests of norfloxacin performed by the ICS method.
    Grimm H
    Eur J Clin Microbiol; 1983 Jun; 2(3):245-8. PubMed ID: 6224681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disk diffusion susceptibility tests with norfloxacin: confirmation of proposed interpretive criteria.
    Wood SJ; Shadomy S
    Eur J Clin Microbiol; 1983 Jun; 2(3):242-4. PubMed ID: 6224680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.
    Body BA; Fromtling RA; Shadomy S; Shadomy HJ
    Eur J Clin Microbiol; 1983 Jun; 2(3):230-4. PubMed ID: 6224678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of norfloxacin in synthetic media and human urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottnad-Walz M; Stille W
    Methods Find Exp Clin Pharmacol; 1983 Dec; 5(10):731-4. PubMed ID: 6231438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of norfloxacin in urine compared to that of cinnoxacin, nalidixic acid and pipemidic acid.
    Shah PM; Ottrad M; Stille W
    Eur J Clin Microbiol; 1983 Jun; 2(3):272-4. PubMed ID: 6224688
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of norfloxacin against multi-resistant bacteria.
    Machka K; Vogelsang G
    Eur J Clin Microbiol; 1983 Jun; 2(3):270-1. PubMed ID: 6224686
    [No Abstract]   [Full Text] [Related]  

  • 7. Interpretation criteria for sensitivity testing of ceftriaxone in agar diffusion test according to the DIN 58940 method.
    Grimm H
    Chemotherapy; 1984; 30(1):49-53. PubMed ID: 6319090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro activity of norfloxacin against urinary tract pathogens.
    Haase D; Urias B; Harding G; Ronald A
    Eur J Clin Microbiol; 1983 Jun; 2(3):235-41. PubMed ID: 6224679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance.
    Greenwood D; Osman M; Goodwin J; Cowlishaw WA; Slack R
    J Antimicrob Chemother; 1984 Apr; 13(4):315-23. PubMed ID: 6233248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of norfloxacin against Chlamydia trachomatis.
    Meier-Ewert H; Weil G; Millott G
    Eur J Clin Microbiol; 1983 Jun; 2(3):271-2. PubMed ID: 6224687
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A; Shannon K; Phillips I
    J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioassay procedures for norfloxacin.
    Bland J; Edison A; Huber J
    Eur J Clin Microbiol; 1983 Jun; 2(3):249-52. PubMed ID: 6224682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of norfloxacin on Staphylococcus aureus and Pseudomonas aeruginosa in broth, serum and in combination with human polymorphonuclear leukocytes.
    Daschner F; Bassler M; Bosbach U
    Eur J Clin Microbiol; 1983 Jun; 2(3):274-6. PubMed ID: 6224689
    [No Abstract]   [Full Text] [Related]  

  • 15. Criteria for the assessment of susceptibility to ceftazidime using the disc diffusion procedure.
    Grimm H
    Infection; 1983; 11 Suppl 1():S35-8. PubMed ID: 6339416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interpretive criteria for the agar diffusion susceptibility test with ofloxacin.
    Grimm H
    Drugs; 1987; 34 Suppl 1():14-9. PubMed ID: 3481315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Belgian multicenter in vitro study of norfloxacin.
    Verbist L
    Acta Clin Belg; 1985; 40(3):167-73. PubMed ID: 3161262
    [No Abstract]   [Full Text] [Related]  

  • 18. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
    Peddie BA
    N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
    [No Abstract]   [Full Text] [Related]  

  • 19. Types of interpretive errors in susceptibility testing. Zone breakpoints for norfloxacin disk diffusion testing.
    Björklind A; Ringertz S; Kronvall G
    APMIS; 1989 Oct; 97(10):941-8. PubMed ID: 2803757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.
    Newsom SW; Matthews J; Amphlett M; Warren RE
    J Antimicrob Chemother; 1982 Jul; 10(1):25-30. PubMed ID: 6213593
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.